SCHEMBL4241496

SCHEMBL4241496

CC(C)(C)OC(=O)NCc1ccc(CNC(=O)c2cccc3cc(N(CC(=O)O)S(=O)(=O)c4cc(Cl)cc(Cl)c4)ccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 4/20 0.39
NFE2L2 Q16236 4/20 0.39
GAA P10253 1/20 0.38
POLA1 P09884 1/20 0.37
HDAC1 Q13547 2/20 0.37
KMT2A Q03164 1/20 0.37
OXTR P30559 1/20 0.36
AVPR1A P37288 1/20 0.36
RORC P51449 1/20 0.36
ACACB O00763 1/20 0.36
ACACA Q13085 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12119299 0.93 KMT2A (0.38) GAAPOLA1HDAC1KMT2AOXTR
SCHEMBL4241494 0.90 KEAP1 (0.36) KEAP1NFE2L2GAAPOLA1HDAC1
SCHEMBL1322546 0.89 GAA (0.43) KEAP1NFE2L2GAAPOLA1HDAC1
SCHEMBL1319769 0.88 GAA (0.42) KEAP1NFE2L2GAAPOLA1HDAC1
SCHEMBL1110201 0.86 POLA1 (0.36) KEAP1NFE2L2GAAPOLA1HDAC1
SCHEMBL12119699 0.86 RORC (0.42) KMT2ARORC
SCHEMBL1321342 0.86 HDAC2 (0.41) KEAP1NFE2L2GAAPOLA1HDAC1
SCHEMBL1318917 0.85 HDAC2 (0.42) KEAP1NFE2L2GAAPOLA1HDAC1
SCHEMBL12119239 0.85 EPHX2 (0.38) GAAPOLA1HDAC1KMT2ARORC
SCHEMBL1319261 0.85 HTT (0.45) KEAP1NFE2L2GAAPOLA1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009127723-A1 NEW ARYLSULPHONYLGLYCINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-22 WO disclosed